Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Qualigen Therapeutics Inc
(NQ:
QLGN
)
0.2027
-0.0070 (-3.34%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Qualigen Therapeutics Inc
Lifecore Biomedical Announces Cooperation Agreement with 22NW
July 01, 2024
Provides for the Addition of 22NW Nominees Jason Aryeh and Matthew Korenberg, as Well as Humberto Antunes and Paul Johnson, to the Board
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft(TM)
April 16, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft(TM)
April 16, 2024
JUPITER, FL - (NewMediaWire) - April 16, 2024 - Marizyme, Inc. ("Marizyme", OTCQB: MRZM) announces today a Co-Development Agreement (the “Agreement”) with Qualigen Therapeutics, Inc. (“Qualigen”)...
Via
TheNewswire.com
Exposures
Product Safety
Qualigen Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Rule
December 12, 2022
From
Qualigen Therapeutics, Inc.
Via
GlobeNewswire
Qualigen Therapeutics Announces Pre-IND Feedback from U.S. Food and Drug Administration Regarding QN-302 for the Treatment of G4-Targeted Advanced Solid Tumors
December 07, 2022
From
Qualigen Therapeutics, Inc.
Via
GlobeNewswire
Qualigen Therapeutics, Inc. Announces 1-for-10 Reverse Stock Split
November 22, 2022
From
Qualigen Therapeutics, Inc.
Via
GlobeNewswire
Qualigen Therapeutics, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 15, 2022
From
Qualigen Therapeutics, Inc.
Via
GlobeNewswire
Qualigen Therapeutics Announces Two Posters of Its RAS-Targeted Inhibitor Program at the National Cancer Institute
October 19, 2022
From
Qualigen Therapeutics, Inc.
Via
GlobeNewswire
Qualigen Therapeutics to Present at LD Micro Main Event XV
October 18, 2022
From
Qualigen Therapeutics, Inc.
Via
GlobeNewswire
Qualigen Therapeutics to Present Two Posters at the National Cancer Institute Fourth RAS Initiative Symposium
October 06, 2022
From
Qualigen Therapeutics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.